References

 
  1. Luger T, De Raeve L, Gelmetti C, Kakourou T, Katsarou A, Lambert J, et al. Recommendations for pimecrolimus 1% cream in the treatment of mild-tomoderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol 2013;23(6):758-766.
  2. Eichenfield L, Tom W, Chamlin S, Feldman S, Hanifin J, Simpson E, et al. Guidelines of care for the management of atopic dermatitis -.Section 1: Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014;70:338-351.
  3. Kempers S, Boguniewicz M, Carter E, Jarratt M, Pariser D, Stewart D, et al. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. J Am Acad Dermatol 2004;51(4):515-525.
  4. Draelos Z. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Curr Med Res Opin 2008;24(4):985-994.
  5. Yosipovitch G, Hundley J. Practical Guidelines for the Relief of Itch. Dermatology Nursing 2004;16(4): Available from: http://www.medscape.com/viewarticle/488914_2 Last accessed 8th December 2015.
  6. Eichenfield L, Lucky A, Boguniewicz M, Langley R, Cherill R, Marshal K, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1 % in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002;46:495-504.
  7. Eichenfield L, Tom W, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis -.Section 2: Management and treatment of atopic dermatitis. J Am Acad Dermatol 2014;71:116-32.
  8. Sargin MR, Hoffstad O, Margolis DJ. Warm, Humid, and High Sun Exposure Climates are Associated with Poorly Controlled Eczema: PEER (Pediatric Eczema Elective Registry) Cohort, 2004–2012. J Invest Dermatol. 2014;134(1): . doi:10.1038/jid.2013.274.
  9. Jordaan HF, Visser WI. The diagnosis and management of atopic dermatitis. SA Fam Pract 2009;51(5):368-374.
  10. Allergy Foundation South Africa. Atopic Eczema / Atopic Dermatitis. Available from http://www.allergyfoundation.co.za/patientinformation/en/allergic-diseases/atopic-eczema-atopic-dermatitis/ Accessed 9 March 2017.
  11. Bieber T. Atopic Dermatitis. N Engl J Med 2008;358:1483-1494.
  12. Spergel J. Immunology and Treatment of Atopic Dermatitis. Am J Clin Dermatol 2008;9(4):233-244.
  13. Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, et al. Guidelines for management of atopic dermatitis. J Dermatol 2009;36:563–
  14. Sinclair W, Aboobaker J, Jordaan F, Modi D, Todd G. Management of atopic dermatitis in adolescents and adults in South Africa. S Afr Med J. 2008; 98: 301-320.
  15. Werfel T, Schwerk N, Hansen G, Kapp A. The Diagnosis and Graded Therapy of Atopic Dermatitis. Dtsch Arztebl Int 2014;111:509–20.
  16. gov.uk. 2017. Aqueous cream: may cause skin irritation. [ONLINE] Available at: https://www.gov.uk/drug-safety-update/aqueous-cream-may-cause-skin-irritation. [Accessed 18 October 2017].
  17. ELIDEL Approved Package Insert. Meda Pharma South Africa (Pty) Ltd; 13 June 2009.
  18. Eczema Association Australasia. eczema-myths-busted. [ONLINE] Available at: http://www.eczema.org.au/eczema-myths-busted/. [Accessed 18 October 2017].